EP0614364A4 - Methods and compositions for treating infection using optically pure (s)-lomefloxacin. - Google Patents

Methods and compositions for treating infection using optically pure (s)-lomefloxacin.

Info

Publication number
EP0614364A4
EP0614364A4 EP9292925403A EP92925403A EP0614364A4 EP 0614364 A4 EP0614364 A4 EP 0614364A4 EP 9292925403 A EP9292925403 A EP 9292925403A EP 92925403 A EP92925403 A EP 92925403A EP 0614364 A4 EP0614364 A4 EP 0614364A4
Authority
EP
European Patent Office
Prior art keywords
lomefloxacin
compositions
methods
optically pure
treating infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP9292925403A
Other languages
German (de)
French (fr)
Other versions
EP0614364A1 (en
Inventor
James W Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of EP0614364A1 publication Critical patent/EP0614364A1/en
Publication of EP0614364A4 publication Critical patent/EP0614364A4/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP9292925403A 1991-11-27 1992-11-25 Methods and compositions for treating infection using optically pure (s)-lomefloxacin. Ceased EP0614364A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US799243 1985-11-18
US79924391A 1991-11-27 1991-11-27
PCT/US1992/010142 WO1993010785A1 (en) 1991-11-27 1992-11-25 Methods and compositions for treating infection using optically pure (s)-lomefloxacin

Publications (2)

Publication Number Publication Date
EP0614364A1 EP0614364A1 (en) 1994-09-14
EP0614364A4 true EP0614364A4 (en) 1994-10-19

Family

ID=25175406

Family Applications (1)

Application Number Title Priority Date Filing Date
EP9292925403A Ceased EP0614364A4 (en) 1991-11-27 1992-11-25 Methods and compositions for treating infection using optically pure (s)-lomefloxacin.

Country Status (5)

Country Link
EP (1) EP0614364A4 (en)
JP (1) JPH07503457A (en)
AU (2) AU3147493A (en)
CA (1) CA2124443A1 (en)
WO (1) WO1993010785A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6075024A (en) 1991-11-27 2000-06-13 Sepracor Inc. Methods for treating infection using optically pure (S)-lomefloxacin

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0140116A1 (en) * 1983-09-19 1985-05-08 Hokuriku Pharmaceutical Co.,Ltd A 6-fluoro-1,4-dihydro-4-oxo-7-substituted piperazinyl-quinoline-3-carboxylic acid derivative and the method for preparing the same
JPS60190777A (en) * 1984-03-12 1985-09-28 Hokuriku Seiyaku Co Ltd Optical active 6,8-difluoro-1,4-dihydro-4-oxo-7-substituted piperazinylquinoline-3-carboxylic acid derivative
JPH01242582A (en) * 1988-03-22 1989-09-27 Hokuriku Seiyaku Co Ltd Production of type i crystal of quinolone-carboxylic acid compound
JPH02115182A (en) * 1988-10-21 1990-04-27 Yoshitomi Pharmaceut Ind Ltd Optically active pyridone-carboxylic acid compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS618538A (en) * 1984-06-25 1986-01-16 Shimizu Constr Co Ltd Air conditioning mechanism in factory or the like

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0140116A1 (en) * 1983-09-19 1985-05-08 Hokuriku Pharmaceutical Co.,Ltd A 6-fluoro-1,4-dihydro-4-oxo-7-substituted piperazinyl-quinoline-3-carboxylic acid derivative and the method for preparing the same
US4528287A (en) * 1983-09-19 1985-07-09 Hokuriku Pharmaceutical Co., Ltd. 6-Fluoro-1, 4-dihydro-4-oxo-7-substituted piperazinylquinoline-3-carboxylic acids and the method for preparing the same
JPS60190777A (en) * 1984-03-12 1985-09-28 Hokuriku Seiyaku Co Ltd Optical active 6,8-difluoro-1,4-dihydro-4-oxo-7-substituted piperazinylquinoline-3-carboxylic acid derivative
JPH01242582A (en) * 1988-03-22 1989-09-27 Hokuriku Seiyaku Co Ltd Production of type i crystal of quinolone-carboxylic acid compound
JPH02115182A (en) * 1988-10-21 1990-04-27 Yoshitomi Pharmaceut Ind Ltd Optically active pyridone-carboxylic acid compound

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
Eur. J. Clin. Microbio. Infec. Dis., 1991, 10 (4) p. 223-23 *
J. Antimicrob. Chemother., 1990, 26 Suppl. abstract *
JPN. J. ANTIBIOT, vol. 42, no. 4, 1989, pages 1017 - 1024 *
PATENT ABSTRACTS OF JAPAN vol. 10, no. 43 (C - 329) 20 February 1986 (1986-02-20) *
PATENT ABSTRACTS OF JAPAN vol. 13, no. 579 (C - 668) 20 December 1989 (1989-12-20) *
PATENT ABSTRACTS OF JAPAN vol. 14, no. 322 (C - 0739) 10 July 1990 (1990-07-10) *
See also references of WO9310785A1 *
T. UNE ET AL.: "IN VITRO ACTIVITY OF DR-3355, AN OPTICALLY ACTIVE OFLOXACIN", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 32, no. 9, 1988, pages 1336 - 1340 *
Translation of JP 60190777 A *

Also Published As

Publication number Publication date
WO1993010785A1 (en) 1993-06-10
JPH07503457A (en) 1995-04-13
AU3147493A (en) 1993-06-28
CA2124443A1 (en) 1993-06-10
EP0614364A1 (en) 1994-09-14
AU1515197A (en) 1997-05-22

Similar Documents

Publication Publication Date Title
EP0604433A4 (en) Composition and method for disease treatment.
GB9208339D0 (en) Treatment composition
GB9127150D0 (en) Novel treatment
AU644245B2 (en) Hair treatment composition
EP0596962A4 (en) Therapeutic compositions and methods.
AU2649092A (en) Desulphurisation treatment
EP0700292A4 (en) Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
GB9024928D0 (en) Novel treatment
GB9226958D0 (en) Produktionsaktieselskab) novel treatment
AU8323291A (en) Fiber treatment apparatus
EP0614364A4 (en) Methods and compositions for treating infection using optically pure (s)-lomefloxacin.
AU7366591A (en) Method and composition for water treatment
GB2261432B (en) Treatment plant
GB2256237B (en) Treatment plant
AU7998691A (en) Compositions for treating hiv-type 1 infection
AU2595692A (en) Hair treatment composition
PH31066A (en) Treatment composition.
GB9024925D0 (en) Novel treatment
GB9105560D0 (en) Novel treatment i
GB9004943D0 (en) Dental compositions,procedure and method
GB9010163D0 (en) Novel treatment i
GB9113042D0 (en) Novel treatment and compositions
EP0760660A4 (en) Treating conditions using optically pure(-)-liarozole
GB9006081D0 (en) Treatment system
GB9115928D0 (en) Novel treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940624

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19940829

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19980303

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 31/495 A, 7A 61P 31/04 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20020610